| Neural prolotherapy | Intra-articular prolotherapy | t test | |
---|---|---|---|---|
 | Mean ± SD | Mean ± SD | T | P |
Total WOMAC score | ||||
 At baseline | 63.8 ± 8.2 | 61.2 ± 7.3 | 1.522 | 0.132 |
 Immediate | 36.8 ± 10.3 | 55.5 ± 8.0 | 9.158 | < 0.001 |
 At 3 months | 37.5 ± 10.6 | 57.2 ± 8.8 | 9.199 | < 0.001 |
 At 6 months | 39.8 ± 10.5 | 58.5 ± 8.3 | 8.919 | < 0.001 |
Repeated measure ANOVA test | ||||
 F | 69.787 | 3.262 |  |  |
 P | < 0.001 | 0.023 |  |  |
WOMAC pain score | ||||
 At baseline | 14.5 ± 2.0 | 14.6 ± 1.7 | 0.181 | 0.857 |
 Immediate | 6.5 ± 1.3 | 12.6 ± 2.3 | 14.984 | < 0.001 |
 At 3 months | 6.9 ± 1.5 | 13.2 ± 2.3 | 15.001 | < 0.001 |
 At 6 months | 7.6 ± 1.7 | 13.7 ± 2.2 | 13.715 | < 0.001 |
Repeated measure ANOVA test | ||||
 F | 218.784 | 6.066 |  |  |
 P | < 0.001 | < 0.001 |  |  |
WOMAC stiffness score | ||||
 At baseline | 4.1 ± 1.2 | 4.2 ± 1.1 | 0.197 | 0.845 |
 Immediate | 1.6 ± 0.8 | 3.1 ± 1.1 | 6.951 | < 0.001 |
 At 3 months | 1.8 ± 1.0 | 3.5 ± 1.2 | 7.004 | < 0.001 |
 At 6 months | 2.7 ± 1.1 | 3.7 ± 1.1 | 4.211 | < 0.001 |
Repeated measure ANOVA test | ||||
 F | 49.956 | 6.948 |  |  |
 P | < 0.001 | < 0.001 |  |  |
WOMAC function score | ||||
 At baseline | 43.0 ± 5.9 | 42.4 ± 4.9 | 1.341 | 0.184 |
 Immediate | 28.7 ± 8.6 | 39.8 ± 5.4 | 7.027 | < 0.001 |
 At 3 month | 28.8 ± 8.8 | 40.4 ± 5.8 | 7.065 | < 0.001 |
 At 6 months | 29.6 ± 8.9 | 41.0 ± 5.4 | 6.988 | < 0.001 |
Repeated measure ANOVA test | ||||
 F | 34.638 | 1.510 |  |  |
 P | < 0.001 | 0.214 |  |  |